What does BCBS North Dakota require to renew Wegovy?

Weight Loss — Applies to Employer and ACA Marketplace plans. Per referenced guidelines, if weight loss ≥ 5% of body weight at 3 months, medication should be continued. If weight loss < 5% at 3 months or safety/tolerability issues, medication should be discontinued. At least 12 weeks on therapy before the first renewal.

How current is this information?

The oldest review date among the policies on this page is June 2, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

BCBS North Dakota coverage for Wegovy (Weight Loss)

Does BCBS North Dakota cover Wegovy for Weight Loss?

Yes. BCBS North Dakota covers Wegovy for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.

Policy document

Nd Weight Management Paql Prog Sum

BCBS North Dakota · PA policy · Employer and ACA Marketplace

Verified June 2, 2026.

View PDF Download Original insurer source

Employer and ACA Marketplace: Covered with requirements. See the qualification pathways below.

Earliest policy review June 2, 2026. How we verify · Check your exact plan

Full requirements: Wegovy for Weight Loss (2 plan types)

Applies to Employer and ACA Marketplace plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Adult obesity without comorbidity

All of:

BMI ≥ 30 kg/m2 (or ≥ 25 kg/m2 for South Asian, Southeast Asian, or East Asian adults)
Inadequate response to comprehensive lifestyle intervention program

Adult overweight with comorbidity

All of:

BMI ≥ 27 kg/m2 (or ≥ 23 kg/m2 for South Asian, Southeast Asian, or East Asian adults)
Inadequate response to comprehensive lifestyle intervention program

Plus any one of:

Hypertension
Type 2 diabetes
Dyslipidemia
Obstructive sleep apnea
Cardiovascular disease
Other weight-related comorbid condition

Pediatric (age ≥ 12) obesity

All of:

Age ≥ 12 years
Body weight > 60 kg
Obesity diagnosis

Documentation to bring

Documentation of BMI ≥ 30 kg/m2 or ≥ 27 kg/m2 with at least one weight-related comorbidity
Documentation of prior comprehensive lifestyle intervention program attempt or reason it is not feasible
Documentation of weight-related comorbid condition if BMI is 27-29.9 kg/m2

Approval and renewal

Renewal: Per referenced guidelines, if weight loss ≥ 5% of body weight at 3 months, medication should be continued. If weight loss < 5% at 3 months or safety/tolerability issues, medication should be discontinued.
Renewal: At least 12 weeks on therapy before the first renewal.

Not covered when

Coadministration with other semaglutide-containing products is not recommended
Coadministration with any other GLP-1 receptor agonist is not recommended

Policy note: Document is a program summary with clinical rationale referencing AHA/ACC/Obesity Society 2013 guidelines, AACE/ACE guidelines, Endocrine Society guidelines, and AGA 2022 guidelines. Full PA criteria details (specific approval criteria, quantity limits) are not fully enumerated in the provided document text. Asian BMI threshold of 23 kg/m2 referenced in AACE guidelines cited within the document for South Asian, Southeast Asian, and East Asian adults. Wegovy is available as both subcutaneous injection and tablet formulations per FDA indications listed. Pediatric indication applies to ages ≥ 12 with body weight > 60 kg.

Policy effective April 20, 2026 · verified June 2, 2026 · source: Nd Weight Management Paql Prog Sum · View policy document (PDF)

Open on its own page →

Questions people ask

Does BCBS North Dakota cover Wegovy?: Yes. BCBS North Dakota covers Wegovy for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.
What does BCBS North Dakota require to renew Wegovy?: Weight Loss — Applies to Employer and ACA Marketplace plans. Per referenced guidelines, if weight loss ≥ 5% of body weight at 3 months, medication should be continued. If weight loss < 5% at 3 months or safety/tolerability issues, medication should be discontinued. At least 12 weeks on therapy before the first renewal.
How current is this information?: The oldest review date among the policies on this page is June 2, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Summary of BCBS North Dakota's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.